Zilico Limited
Zilico is developing the next generation of cancer diagnostics. Zilico’s flagship product is a medical device diagnostic for cervical cancer. ZedScan utilises patented bioelectric technology to differentiate between normal, pre-cancer and cancerous tissue and deliver this analysis in real-time. ZedScan is already in routine use across NHS hospitals and published real-world data shows how it helps better manage patient outcomes. The platform technology is being applied for other indications such as oral cancer.
Website |www.zilico.co.uk
Schedule a 1:1 business networking meeting with Zilico
